Aditya Bagrodia

So today we're going to talk about suction devices and suction technologies and kidney stone treatment. And I'm excited. You know, taking a walk down memory lane, largely it was lasers, fragment, basket retrieval for as long as that was required. Then dusting kind of came on the scene as like a new thing. And that seems to be kind of a...

ongoing debate in the minimally invasive endourology world. And then for PCNLs, it was like a cyber one, which was, I think, pulverized the stone and then somehow suctioned it up. Those were kind of the tools that I had in my toolkit, more or less. And maybe just ask you to kind of comment on, you know, what's transpired over the last decade or so.

ongoing debate in the minimally invasive endourology world. And then for PCNLs, it was like a cyber one, which was, I think, pulverized the stone and then somehow suctioned it up. Those were kind of the tools that I had in my toolkit, more or less. And maybe just ask you to kind of comment on, you know, what's transpired over the last decade or so.

ongoing debate in the minimally invasive endourology world. And then for PCNLs, it was like a cyber one, which was, I think, pulverized the stone and then somehow suctioned it up. Those were kind of the tools that I had in my toolkit, more or less. And maybe just ask you to kind of comment on, you know, what's transpired over the last decade or so.

Well, actually, I was thinking about this upcoming podcast and just...

Well, actually, I was thinking about this upcoming podcast and just...

Well, actually, I was thinking about this upcoming podcast and just...

Absolutely. Yeah, no, it's perfect. I mean, the three main approaches are percutaneous, and it still blows my mind that once upon a time, a couple of urologists decided to start harpooning through the back, aiming for a fairly small area, and just kind of seeing how that all went. Yeah.

Absolutely. Yeah, no, it's perfect. I mean, the three main approaches are percutaneous, and it still blows my mind that once upon a time, a couple of urologists decided to start harpooning through the back, aiming for a fairly small area, and just kind of seeing how that all went. Yeah.

Absolutely. Yeah, no, it's perfect. I mean, the three main approaches are percutaneous, and it still blows my mind that once upon a time, a couple of urologists decided to start harpooning through the back, aiming for a fairly small area, and just kind of seeing how that all went. Yeah.

So, okay, maybe to bring it to a little bit more contemporary times, if we're talking about the endoscopic options, percutaneous nephrolithotomy or ureteroscopy, now we're looking at breaking stones up, removing them, fragmenting them to really teeny tiny pieces that ostensibly pass... Is that it or is there more going on here?

So, okay, maybe to bring it to a little bit more contemporary times, if we're talking about the endoscopic options, percutaneous nephrolithotomy or ureteroscopy, now we're looking at breaking stones up, removing them, fragmenting them to really teeny tiny pieces that ostensibly pass... Is that it or is there more going on here?

So, okay, maybe to bring it to a little bit more contemporary times, if we're talking about the endoscopic options, percutaneous nephrolithotomy or ureteroscopy, now we're looking at breaking stones up, removing them, fragmenting them to really teeny tiny pieces that ostensibly pass... Is that it or is there more going on here?

You know, it's amazing. Before I committed to a career in oncology, one of my first mentors was Peggy Pearl, who's an amazing, very rigorous stone surgeon. And we wrote a paper on natural history of visual fragments after PCNL. I think you might be quoting ureteroscopy data, but it was spot on. And Peggy would, let's just say, diligently analyze

You know, it's amazing. Before I committed to a career in oncology, one of my first mentors was Peggy Pearl, who's an amazing, very rigorous stone surgeon. And we wrote a paper on natural history of visual fragments after PCNL. I think you might be quoting ureteroscopy data, but it was spot on. And Peggy would, let's just say, diligently analyze

You know, it's amazing. Before I committed to a career in oncology, one of my first mentors was Peggy Pearl, who's an amazing, very rigorous stone surgeon. And we wrote a paper on natural history of visual fragments after PCNL. I think you might be quoting ureteroscopy data, but it was spot on. And Peggy would, let's just say, diligently analyze

painstakingly get every residual fragments out because her belief was anything left behind was going to misbehave or certainly could misbehave.

painstakingly get every residual fragments out because her belief was anything left behind was going to misbehave or certainly could misbehave.

painstakingly get every residual fragments out because her belief was anything left behind was going to misbehave or certainly could misbehave.

Well, you know, on the provider side, you know, maybe two or three times a year, feeling reasonably well-trained in ureteroscopy over the course of my residency and fellowship, I'll do a stone case. And I always really appreciate the endourologist, too, who I think really hold themselves accountable to doing their level best with the stone because...